SURGE
PrivateLast Round
Series B
Jul 19, 2023
Total Funding Raised
$58M
Company Overview
SURGE Therapeutics is a biotechnology company that specializes in a proprietary technology-based platform for delivering localized immunotherapy through an injectable biodegradable hydrogel designed to enhance cancer treatment during surgical tumor resection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SURGE Comps
Public and private peers based on sector, stage, and business model.
SURGE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 19, 2023 | ||||
| Series A | Oct 17, 2022 |
Key People
Founding team and executive leadership
SURGE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Camford Capital | Series B, Series A |
| Bioluminescence Ventures | Series B |
| Khosla Ventures | Series A, Series B |
| Intuitive Ventures | Series B, Series A |
| Cancer Research Institute | Series A, Series B |
| 8VC | Series A, Series B |
| Alumni Ventures | Series A, Series B |
SURGE Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SURGE's valuation, stock price, and market status.
